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Bovine Somatotropin in Milk
What is Bovine
Somatotropin?
Bovine Somatotropin (BST),
also called bovine growth hormone
(BGH), is a hormone produced by
the cow's pituitary gland. It, like
other hormones, is produced in small
quantities and is used in regulating
metabolic processes. In the early
stages of a calf's development, it
acts as a growth hormone. During
lactation, it serves to mobilize body
fat to use for energy and diverts feed
energy more toward milk production than for tissue synthesis.
BST is a protein hormone like
insulin, not a steroid hormone like
the sex hormones and cortisone.

Why inject cows
with BST?
BSThas the potential to increase
the efficiency of milk production.
Potentially 10-15% more milk can
be obtained from each cow with a
cost of implementation of less than
5%.

Sources of BST/BGH
Early research efforts used crude
extracts from bovine pituitary
glands. Although the treated cows
increased their milk production, the
amount of available BST was too
limited for commercial use.
Biotechnology research received the impetus to produce hormones using genetically engineered
bacteria because of our need for
insulin. Insulin is also a protein
hormone. The insulin isolated from
the pancreas of animals IS active in
man when given by injection and
was the source of insulin for diabetics for many years. In the early
1980's, biotechnology made it possible, through use of recombinant
DNA gene splicing, to produce insulin from bacterial cells. Today
almost all insulin used for human
injection comes from this manufacturing technique. The procedure
for production of BST is conceptually identical. Biotechnology is also
used today to produce human growth
hormone to control dwarfism and
interferon to treat a form of adult
leukemia. BST is the first product
approved for use in food animals
through this technology.

Biotechnology
production of BST
The genes responsible for production of BST in cattle were identified in bovine tissue cells; they
cause the pituitary cells to produce
the biological product BST. These
genes were isolated and inserted into
a specific bacteria as part of a plasmid, with gene splicing. As these
altered bacteria replicate, the new
genes are also replicated and passed
along to all new bacteria. The presence of these genes causes the bacterial cell to become a little "manufacturing plant" which produces BST
in large quantities. Eventually the
bacterial cells are killed and removed, leaving the purified BST.

BST in milk
There are four different natural
forms of the BSThormone, withjust
slightly different chemical structures. The synthetic form of BST
cannot be distinguished in the milk
from the natural form. All milk
contains minuscule amounts ofBST
regardless ofwhether from untreated
cows or cows treated with BST. It is
not possible, through testing of the

milk, to tell if the cow has been
treated with BST.

Effect of BST on
humans
An early test of bovine growth
hormone was as a possible treatment for children suffering from
hypopituitary dwarfism. Although
the bovine hormone was injected in
large doses, it did not affect the
children. An extract from human
pituitary glands was successful.
There is not enough similarity between human and bovine growth
hormone for bovine produced
growth hormone to cause desirable
or undesirable effects in humans.
BST is digested by humans just
like any other protein. Therefore,
even if it were active in the human
body, one would not obtain the
active hormone by drinking milk or
eating cheese. About 90% ofBST is
destroyed during pasteurization and
it is also denatured by processing for
baby formula.
After careful review, the Food
and Drug Administration, World
Health Organization, American
Medical Association, American DieteticsAssociation, and the National
Institute of Health have independently confirmed that dairy products and meat from BSTtreated cows
are safe for human consumption.

Insulin-like growth
factors
Insulin-like growth factors I and
II are involved with growth hormones therefore they need to be
considered. IGF-II does not increase
when cows are treated with BST;
there is a slight increase in IGF-I. It
is higher in human milk than in milk
from treated cows. If it were injected, IGF-I could be active in humans. IGF-I is not destroyed during
pasteurization of milk, however the
heat treatment used producing baby
formula does destroy this hormone.
It is also destroyed when milk or
meat is cooked. Since it a protein,
it is digested by both adults and
infants, and therefore is not considered a problem.

Composition of milk
from cows treated with
BST
There are no differences in milk
composition from cows treated with
BST and from cows which were not
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treated. All cows produce BST and
all milk contains BST. Protein, butterfat, vitamins, calcium and other
minerals remain the same. Natural
variations occur between cows, but
these cannot be related to which
treatment the cow received. Neither
is Flavor of the milk affected. Consumers are not able to pick out the
milk from cows treated with BST as
compared to milk from control cows.

Why is the use of BST
controversial?
First, as a new technology, the
use of BST can cause apprehension
in some consumers. This in turn
worries the processors and the milk
producers. They don't want to deter
dairy product consumption!
Second, it may affect the dairy
economy. More milk can be produced from the same number ofcows
resulting in an increased milk supply. Some dairymen worry about
competition with herds which may
be using BST. Economic pressures
on the dairy industry will continue
regardless of the availability ofBST.
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